COMMUNITY ENGAGEMENT AND PARTNERSHIP (CEP)
COMMUNITY ENGAGEMENT AND PARTNERSHIP (CEP)
批准号:
10748640
负责人:
Lisa Goldman Rosas
金额:
$52.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-17 至 2030-07-31
关键词:
AffectAnemiaAsianBiomedical ResearchBlack raceClinicalCommunicationCommunitiesCountryDataDedicationsEquityGoalsGrantHealthHealth Services AccessibilityHealthcareHemorrhageIncomeIndividualInequityInterventionLatinxLeadershipLearningMaternal HealthMaternal MortalityMaternal health equityMental HealthMothersNative AmericansOutcomeOutcome StudyPatient-Focused OutcomesPatientsPersonsPhasePoliciesPopulationPostpartum HemorrhagePostpartum PeriodProviderResearchResearch PriorityResearch Project GrantsResearch TrainingResourcesRiskTrainingTranslatingTranslational ResearchTranslationsUniversitiesWorkcommunity engaged researchcommunity engagementcommunity organizationscommunity partnershipdesigndigitaldisparity reductionexperiencehealth equity promotionimprovedinnovationobstetrical complicationpatient engagementphysical conditioningpregnantpreventprogramssevere maternal morbidityuptake
中文摘要
项目摘要
社区参与和伙伴关系部分(CEP)的目标是确保
将患者和关键利益相关者纳入PRIHSM研究的所有阶段
促进孕产妇健康公平。PRIHSM专注于产后出血(PPH),这是
这是导致严重孕产妇发病率(SMM)和孕产妇死亡的最常见原因之一。
PRIHSM优先考虑那些承担PPH不成比例负担的群体,其中包括亚洲人,
黑人、拉丁裔和美国原住民,那些建立母亲-母亲伙伴关系的人,以及
有限的资源和获得护理的机会。在患者和社区参与的同时
生物医学研究日益被认为是促进健康公平的最佳做法,
在确定SMM的研究重点方面缺乏参与,对SMM的理解也有限
产科并发症后患者的生活经历。这些限制甚至更多
史塔克在考虑严重的产后出血及其短期和长期身体和
心理健康结果,这是PRIHSM研究项目的重点。强壮,
双向的患者和社区伙伴关系和有效的参与战略是
对于确定和实施最有希望的干预措施以减少差距至关重要
SMM和PPH引起的孕产妇死亡率。因此,CEP将与以下机构建立双向伙伴关系
患者、关键利益相关者和最能代表人民的社区组织
通过以下具体目标影响研究结果:目标1.建立、加强和
保持社区-大学双向伙伴关系,重点是改善孕产妇健康
公平;目标2.将患者、提供者和医疗保健领导层的观点整合到
PRIHSM的研究,使用量身定做的创新参与策略,如数据故事讲述
和研究优先活动,以推广合作伙伴驱动的解决方案,以改善患者-
以结果为中心。目标3.制定和实施传播PRIHSM的战略
向广大受众公布研究结果,并将其转化为临床政策和实践,以促进
卫生公平,使用创新方法,如向社区合作伙伴提供微型赠款、数字
研究结果的故事讲述,以及面对面的社区聚会,以促进最大限度地
参与和吸收关键的健康信息。这些目标中的每个都是协同一致的
与我们的研究项目和培训目标相一致。这些目标的成功实现将
形成强大、可持续的社区-大学合作伙伴关系,致力于改善孕产妇
卫生公平,并为成功的社区参与创建最佳实践蓝图
研究的重点是产妇健康。
英文摘要
Project Summary
The goal of the Community Engagement and Partnership component (CEP) is to ensure
that patients and key stakeholders are integrated into all phases of PRIHSM’s research to
promote maternal health equity. PRIHSM focuses on postpartum hemorrhage (PPH), which is
one of the most common causes of severe maternal morbidity (SMM) and maternal mortality.
PRIHSM prioritizes groups that bear the disproportionate burden of PPH, which includes Asian,
Black, Latinx and Native American individuals, those in mother-mother partnerships, and people
with limited resources and access to care. While engagement of patients and communities in
biomedical research is increasingly recognized as a best practice for promoting health equity,
there is a dearth of engagement in setting research priorities for SMM and limited understanding
of patients’ lived experiences after an obstetric complication. These limitations are even more
stark when considering issues such as severe PPH and its short and long term physical and
mental health outcomes, which are the focus of PRIHSM’s research projects. Strong,
bidirectional patient and community partnerships and effective engagement strategies are
essential for identifying and implementing the most promising interventions to reduce disparities
in SMM and maternal mortality due to PPH. Thus, CEP will create bidirectional partnerships with
patients, key stakeholders, and community-based organizations that represent people most
affected by the study outcomes through these Specific Aims: Aim 1. Build, strengthen, and
sustain bidirectional community-university partnerships focused on improving maternal health
equity; Aim 2. Integrate perspectives of patients, providers, and healthcare leadership into
PRIHSM’s research, using tailored, innovative engagement strategies such as data storytelling
and research prioritization activities to promote partner-driven solutions to improve patient-
centered outcomes. Aim 3. Develop and implement strategies to disseminate PRIHSM’s
findings to a broad audience and translate them into clinical policy and practice to promote
health equity, using innovative approaches such as mini-grants to community partners, digital
storytelling of study findings, and in-person community gatherings to facilitate maximum
engagement and uptake of key health information. Each of these aims is synergistically aligned
with our research projects and training objectives. Successful completion of these Aims will
result in strong, sustainable community-university partnerships dedicated to improving maternal
health equity and create a blueprint of best practices for successful community-engaged
research focused on maternal health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes
-
批准号:10852742
-
项目类别:
-
资助金额:$10.97万
-
财政年份:2021
-
负责人:Lisa Goldman Rosas
-
依托单位:
The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes
-
批准号:10461912
-
项目类别:
-
资助金额:$62.53万
-
财政年份:2021
-
负责人:Lisa Goldman Rosas
-
依托单位:
The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes
-
批准号:10309810
-
项目类别:
-
资助金额:$67.0万
-
财政年份:2021
-
负责人:Lisa Goldman Rosas
-
依托单位:
The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes
-
批准号:10621914
-
项目类别:
-
资助金额:$60.23万
-
财政年份:2021
-
负责人:Lisa Goldman Rosas
-
依托单位:
Outreach, Recruitment and Engagement Core
-
批准号:10409746
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2020
-
负责人:Lisa Goldman Rosas
-
依托单位:
Outreach, Recruitment and Engagement Core
-
批准号:10647876
-
项目类别:
-
资助金额:$30.62万
-
财政年份:2020
-
负责人:Lisa Goldman Rosas
-
依托单位:
implementation
-
批准号:9896675
-
项目类别:
-
资助金额:$17.82万
-
财政年份:--
-
负责人:Lisa Goldman Rosas
-
依托单位:
implementation
-
批准号:9146205
-
项目类别:
-
资助金额:$16.19万
-
财政年份:--
-
负责人:Lisa Goldman Rosas
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: